Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Glycerol Excipient

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ADMELOG SOLOSTAR

    02 1BASAGLAR

    03 1HUMULIN R

    04 1HUMULIN R KWIKPEN

    05 1LEVEMIR

    06 1LEVEMIR FLEXPEN

    07 1LEVEMIR FLEXTOUCH

    08 1LEVEMIR INNOLET

    09 1LEVEMIR PENFILL

    10 1NOVOLOG

    11 1NOVOLOG FLEXPEN

    12 1NOVOLOG FLEXTOUCH

    13 1NOVOLOG INNOLET

    14 1NOVOLOG MIX 70/30

    15 1NOVOLOG MIX 70/30 FLEXPEN

    16 1NOVOLOG MIX 70/30 PENFILL

    17 1NOVOLOG PENFILL

    18 1TRESIBA

    19 1XULTOPHY 100/3.6

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    SANOFI-AVENTIS US
    France
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    INSULIN LISPRO

    Drug : ADMELOG SOLOSTAR

    Dosage Form : SOLUTION; SUBCUTANEOUS

    Application Number : 209196

    Country : US

    Patented : No

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    NOVO NORDISK INC

    INSULIN DETEMIR RECOMBINANT

    arrow
    VMX
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN DETEMIR RECOMBINANT

    Drug : LEVEMIR

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21536

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG MIX 70/30 PENFILL

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21172

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG MIX 70/30 FLEXPEN

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21172

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG MIX 70/30

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 21172

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    VMX
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG FLEXTOUCH

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    VMX
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG PENFILL

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    VMX
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG INNOLET

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    VMX
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG FLEXPEN

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    NOVO NORDISK INC

    INSULIN ASPART RECOMBINANT

    arrow
    VMX
    Not Confirmed
    NOVO NORDISK INC
    Denmark
    arrow
    VMX
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    INSULIN ASPART RECOMBINANT

    Drug : NOVOLOG

    Dosage Form : INJECTABLE; SUBCUTANEOUS

    Application Number : 20986

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.